QIAGEN

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

CEO

Thierry L. Bernard

CEOThierry L. Bernard

Employees

5,654

Employees5,654

Headquarters

Venlo, Limburg

HeadquartersVenlo, Limburg

Founded

1996

Founded1996

Employees

5,654

Employees5,654

QGEN Key Statistics

Market cap

7.25B

Market cap7.25B

Price-Earnings ratio

18.03

Price-Earnings ratio18.03

Dividend yield

0.75%

Dividend yield0.75%

Average volume

2.39M

Average volume2.39M

High today

$35.42

High today$35.42

Low today

$34.96

Low today$34.96

Open price

$35.04

Open price$35.04

Volume

1.15M

Volume1.15M

52 Week high

$57.82

52 Week high$57.82

52 Week low

$32.53

52 Week low$32.53

Stock Snapshot

With a market cap of 7.25B, QIAGEN(QGEN) trades at $35.17. The stock has a price-to-earnings ratio of 18.03 and currently yields dividends of 75.4%.

On 2026-05-23, QIAGEN(QGEN) stock moved within a range of $34.96 to $35.42. With shares now at $35.17, the stock is trading +0.6% above its intraday low and -0.7% below the session's peak.

Trading activity shows a volume of 1.15M, compared to an average daily volume of 2.39M.

The stock's 52-week range extends from a low of $32.53 to a high of $57.82.

QGEN News

TipRanks 7h

Norges Bank Discloses 3.07% Stake in Qiagen

Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, person...

Nasdaq 1d

QIAGEN Stock Up on the Launch of AI-Powered Workflow Agent Platform

QIAGEN QGEN recently launched QIA Agent, an AI-powered digital assistant designed to simplify how researchers plan experiments, identify products, access techni...

Simply Wall St 3d

Qiagen Faces Legal Review As QuantiFERON Outlook Shifts And Valuation Draws Focus

A law firm has launched an investigation into Qiagen (NYSE:QGEN) following the company’s revision of its growth expectations for QuantiFERON sales. The review...

Analyst ratings

62%

of 21 ratings

Buy

38.1%

Hold

61.9%

Sell

More QGEN News

TipRanks 3d

Qiagen Digital Insights to integrate Nvidia accelerated computing

Qiagen (QGEN) announced at the 2026 BIO-IT World Conference & Expo in Boston that the Qiagen Digital Insights bioinformatics business and its curated knowledge...

TipRanks 4d

Bank of America Discloses 2.98% Stake in Qiagen via AFM Filing

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 5d

Qiagen price target lowered to $36 from $50 at Stifel

Stifel lowered the firm’s price target on Qiagen (QGEN) to $36 from $50 and keeps a Hold rating on the shares citing a lower growth outlook after the company st...

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.